Population-based cohort study assessing the effectiveness of maternal BNT162b2/mRNA-1273 vaccination against infant coronavirus disease 2019 outcomes during Omicron predominance: The VENUS study. [PDF]
Hum Vaccin ImmunotherIshiguro C +4 more
europepmc +1 more source
A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers. [PDF]
Front ImmunolCabrera-Serrano AJ +12 more
europepmc +1 more source
Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children. [PDF]
Open Forum Infect DisAglipay M +7 more
europepmc +1 more source
Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age. [PDF]
PediatricsDalapati T +15 more
europepmc +1 more source
COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th<sub>2</sub> cytokines in a systemic mastocytosis patient. [PDF]
Inflamm ResWeiss-Tessbach M +8 more
europepmc +1 more source
Medium-vessel vasculitis following COVID-19 moderna (mRNA-1273) vaccination and the utility of PET-CT as a diagnostic tool: a case report. [PDF]
EJNMMI RepCherk MH, Zolio L, Khan S, Brady S.
europepmc +1 more source
Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients. [PDF]
J Infect DisFigueroa AL +11 more
europepmc +1 more source
Immune Imprinting, Non-Durable Hybrid Immunity, and Hybrid Immune Damping Following SARS-CoV-2 Primary Vaccination with BNT162b2 and Boosting with mRNA-1273. [PDF]
Vaccines (Basel)Erice A, Nuño N, Prieto L, Caballero C.
europepmc +1 more source